Skip to main content

Search

16 result(s) for 'author#Rolf Kiessling' within BMC

Page 1 of 1

Sort by: Relevance | Date

  3. Combination strategies surely play a crucial role in treatment of cancer. Stereotactic ablative radiotherapy (SABR) has been described to induce abscopal effects particularly in renal cell cancer metastases. T...

    Authors: Giuseppe V Masucci, Peter Wersäll, Rolf Kiessling, Andreas Lundqvist and Rolf Lewensohn
    Citation: Journal of Translational Medicine 2012 10:104
    Content type: Commentary Published on:

  4. MELANOMA BRIDGE 2015

    Authors: Vashisht G. Y. Nanda, Weiyi Peng, Patrick Hwu, Michael A. Davies, Gennaro Ciliberto, Luigi Fattore, Debora Malpicci, Luigi Aurisicchio, Paolo Antonio Ascierto, Carlo M. Croce, Rita Mancini, Stefani Spranger, Thomas F. Gajewski, Yangyang Wang, Soldano Ferrone, Claire Vanpouille-Box…
    Citation: Journal of Translational Medicine 2016 14(Suppl 1):65
    Content type: Meeting Abstracts Published on:

    This article is part of a Supplement: Volume 14 Supplement 1

  6. Authors: Andreas Lundqvist, Vincent van Hoef, Xiaonan Zhang, Erik Wennerberg, Julie Lorent, Kristina Witt, Laia Masvidal Sanz, Shuo Liang, Shannon Murray, Ola Larsson, Rolf Kiessling, Yumeng Mao, John-William Sidhom, Catherine A. Bessell, Jonathan Havel, Jonathan Schneck…
    Citation: Journal for ImmunoTherapy of Cancer 2016 4(Suppl 1):82
    Content type: Meeting abstracts Published on:

    This article is part of a Supplement: Volume 4 Supplement 1

  7. Adjuvant trastuzumab (Herceptin) treatment of breast cancer patients significantly improves their clinical outcome. Vaccination is an attractive alternative approach to provide HER-2/neu (Her2)-specific antibo...

    Authors: Håkan Norell, Isabel Poschke, Jehad Charo, Wei Z Wei, Courtney Erskine, Marie P Piechocki, Keith L Knutson, Jonas Bergh, Elisabet Lidbrink and Rolf Kiessling
    Citation: Journal of Translational Medicine 2010 8:53
    Content type: Research Published on:

  8. The estrogen receptor (ER)-positive breast cancer represents over 80% of all breast cancer cases. Even though adjuvant hormone therapy with tamoxifen (TMX) is saving lives of patients with ER-positive breast c...

    Authors: Madhurendra Singh, Xiaolei Zhou, Xinsong Chen, Gema Sanz Santos, Sylvain Peuget, Qing Cheng, Ali Rihani, Elias S. J. Arnér, Johan Hartman and Galina Selivanova
    Citation: Breast Cancer Research 2020 22:80
    Content type: Research article Published on:

  10. HLA abnormalities on tumour cells for immune escape have been widely described. In addition, cellular components of the tumour microenvironment, in particular myeloid derived suppressor cells (MDSC) and altern...

    Authors: Maddalena Marchesi, Emilia Andersson, Lisa Villabona, Barbara Seliger, Andreas Lundqvist, Rolf Kiessling and Giuseppe V Masucci
    Citation: Journal of Translational Medicine 2013 11:247
    Content type: Review Published on:

  11. Scientific discoveries that provide strong evidence of antitumor effects in preclinical models often encounter significant delays before being tested in patients with cancer. While some of these delays have a ...

    Authors: Bernard A Fox, Dolores J Schendel, Lisa H Butterfield, Steinar Aamdal, James P Allison, Paolo Antonio Ascierto, Michael B Atkins, Jirina Bartunkova, Lothar Bergmann, Neil Berinstein, Cristina C Bonorino, Ernest Borden, Jonathan L Bramson, Cedrik M Britten, Xuetao Cao, William E Carson…
    Citation: Journal of Translational Medicine 2011 9:214
    Content type: Commentary Published on:

  12. Malignancies induce changes in the levels of serum amino acids (AA), which may offer diagnostic potential. Furthermore, changes in AA levels are associated with immune cell function. In this study, serum AA le...

    Authors: Isabel Poschke, Yumeng Mao, Rolf Kiessling and Jana de Boniface
    Citation: Journal of Translational Medicine 2013 11:290
    Content type: Research Published on:

  13. Accumulating pre-clinical data indicate that the efficient induction of antigen-specific cytotoxic CD8+ T cells characterizing viral infections is caused by cross-priming where initially infected DCs produce a...

    Authors: Anna Laurell, Maria Lönnemark, Einar Brekkan, Anders Magnusson, Anna Tolf, Anna Carin Wallgren, Bengt Andersson, Lars Adamson, Rolf Kiessling and Alex Karlsson-Parra
    Citation: Journal for ImmunoTherapy of Cancer 2017 5:52
    Content type: Research article Published on:

  14. The fourth “Melanoma Bridge Meeting” took place in Naples, December 3–6th, 2014. The four topics discussed at this meeting were: Molecular and Immunological Advances, Combination Therapies, News in Immunothera...

    Authors: Paolo A. Ascierto, Michael Atkins, Carlo Bifulco, Gerardo Botti, Alistair Cochran, Michael Davies, Sandra Demaria, Reinhard Dummer, Soldano Ferrone, Silvia Formenti, Thomas F. Gajewski, Claus Garbe, Samir Khleif, Rolf Kiessling, Roger Lo, Paul Lorigan…
    Citation: Journal of Translational Medicine 2015 13:374
    Content type: Meeting report Published on:

  15. Harnessing the immune system and preventing immune escape, the immunotherapy of cancer provides great potential for clinical application, in broad patient populations, achieving both conventional and unconvent...

    Authors: Paolo A. Ascierto, Maria Libera Ascierto, Silvia Formenti, Sacha Gnjatic, Hans Hammers, Vera Hirsh, Rolf Kiessling, Ignacio Melero, Rita Nanda, Graham Pawelec, Sandro Pignata, Pedro Romero, Daniel E. Speiser, Bernard A. Fox and Francesco M. Marincola
    Citation: Journal for ImmunoTherapy of Cancer 2016 4:62
    Content type: Meeting report Published on:

  16. Molecular subtypes of breast cancer and presence of tumor-infiltrating immune cells have both been implicated as important predictive and prognostic factors for improved risk stratification and treatment indiv...

    Authors: M. Miyan, J. Schmidt-Mende, R. Kiessling, I. Poschke and J. de Boniface
    Citation: Journal of Translational Medicine 2016 14:227
    Content type: Research Published on: